SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-15-333982
Filing Date
2015-09-30
Accepted
2015-09-30 16:37:01
Documents
4
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d57033d6k.htm 6-K 12861
2 EX-99.1 d57033dex991.htm EX-99.1 3932
3 EX-99.2 d57033dex992.htm EX-99.2 77035
4 EX-99.3 d57033dex993.htm EX-99.3 270597
  Complete submission text file 0001193125-15-333982.txt   365386
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37558 | Film No.: 151134239
SIC: 2834 Pharmaceutical Preparations